Octant
PrivateLast Round
Grant
Jun 11, 2025
Total Funding Raised
$124.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Octant is a biotechnology company that develops synthetic biology and machine learning platforms to engineer small-molecule therapeutics for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octant Comparables
Compare Octant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terray Therapeutics | 80% | |
| Superluminal Medicines | 79% | |
| Genesis Therapeutics | 78% |
Octant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 11, 2025 | ||||
| Grant | Apr 1, 2025 | ||||
| Series B | Apr 21, 2022 | ||||
| Series A | May 20, 2020 |
Octant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B, Series A |
| SV Angel | Series A |
| Allen & Company | Series B, Series A |
| Gates Family Foundation | Grant |
| Catalio Capital Management | Series B |
| Bill & Melinda Gates Foundation | Grant |
| 8VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 39% MoM, reaching 11.8K.
- Jul 27, 2026
Monthly visitors grew 35% MoM, reaching 8.5K.
Octant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Octant's valuation, stock price, and market status.
Is Octant a public or private company?
Octant is a private company.
What is the current stock price of Octant?
Octant is a private company with no public stock price. No recent secondary market data is available.
How much is Octant worth (valuation)?
Valuation information for Octant is not publicly available.
Can I buy Octant stock?
Octant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Octant's last funding round?
Octant's most recent funding round was Grant on June 11, 2025.
Who are the main investors in Octant?
Key investors in Octant include Andreessen Horowitz, Catalio Capital Management.
Will Octant IPO soon?
No public IPO plans have been announced for Octant.
How can I track Octant secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Octant's secondary market activity and sign up for updates.